BRCA1 and breast cancer: BRCA1 is mutated in less than 1–7% of BC tumors when patients are not selected for family history [14, 15], but when altered it is a robust biomarker for BC susceptibility with mutation carriers having a lifetime risk of up to 85% for BC [1, 16, 17].